Morgan Stanley
ZURA icon

Morgan Stanley’s Zura Bio ZURA Stock Holding History

Morgan Stanley’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99M Sell
505,953
-366,997
-42% -$1.75M ﹤0.01% 4593
2026
Q1 		$5.19M Sell
872,950
-636,461
-42% -$3.84M ﹤0.01% 4104
2025
Q4 		$7.91M Buy
1,509,411
+1,299,985
+621% +$5.14M ﹤0.01% 3813
2025
Q3 		$907K Sell
209,426
-39,774
-16% -$71.5K ﹤0.01% 5221
2025
Q2 		$262K Buy
249,200
+165,291
+197% +$198K ﹤0.01% 5744
2025
Q1 		$108K Sell
83,909
-30,199
-26% -$47.6K ﹤0.01% 5973
2024
Q4 		$285K Sell
114,108
-16,842
-13% -$60K ﹤0.01% 5652
2024
Q3 		$532K Buy
130,950
+95,505
+269% +$357K ﹤0.01% 5372
2024
Q2 		$124K Buy
35,445
+13,285
+60% +$54.2K ﹤0.01% 5882
2024
Q1 		$57K Sell
22,160
-36,324
-62% -$129K ﹤0.01% 6164
2023
Q4 		$273K Buy
58,484
+41,401
+242% +$207K ﹤0.01% 5584
2023
Q3 		$113K Buy
17,083
+11,657
+215% +$77.9K ﹤0.01% 5835
2023
Q2 		$44.5K Buy
+5,426
New +$43.6K ﹤0.01% 6255

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Morgan Stanley's ZURA Position: Q2 2026 in Review

Morgan Stanley reduced its Zura Bio (ZURA) stake by 42% in Q2 2026, selling an estimated $1.75M and leaving 505,953 shares worth $2.99M. The position accounts for ﹤0.01% of the portfolio, ranked #4593.

Morgan Stanley first reported a position in ZURA in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.91M in Q4 2025. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Morgan Stanley held 505,953 shares of Zura Bio worth $2.99M as of Q2 2026.
  • Morgan Stanley sold 366,997 Zura Bio shares in Q2 2026, an estimated $1.75M.
  • Zura Bio made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4593 holding.
  • Morgan Stanley first reported a position in Zura Bio in Q2 2023 and has held it in 13 quarters since.
  • Morgan Stanley's Zura Bio position peaked at $7.91M in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.